E. coli High-Yield Cell-Free Protein Expression Kit
Built for diverse needs and high‑performance workflows, this cell-free protein expression kit leverages the Continuous Exchange Cell-Free (CECF) principle along with an enhanced E.coli lysate to achieve medium-to-preparative-scale protein yields from plasmid DNA. It supports efficient and scalable production of up to 6-mg protein per run.
- High-yield CECF system enables optimized plasmid-based expression scalable from 0.5 mg to 6 mg per 1-mL reaction.
- Ideal for structural biology workflows including NMR spectroscopy and X-ray crystallography thanks to a preparative-scale yield.
- Flexible amino acid supply allows substitution of methionine for labeling studies.
- Optimized for thermomixer-based operation, ensuring consistent CECF exchange and robust yields.
E. coli Cell-Free Protein Expression Kit
Go from genes to proteins in hours. This fast cell‑free protein synthesis system uses optimized E. coli lysates and supports both circular and linear DNA templates to produces up to 20 µg of functional protein in 4 hours. Ideal for rapid screening, parallel expression, and workflow scaling in tubes or microplates.
- High yield E. coli lysate drives efficient coupled transcription/translation, generating up to 20 µg protein per 50 µL reaction in 4 h.
- Supports linear and plasmid DNA for rapid construct screening without cloning, improving early expression workflows.
- Flexible format works in microplates or tubes, enabling scalable, parallelized protein production.
- Suitable for optimization studies, including chaperone or additive screening to enhance active protein yield.
This validated controls kit is engineered for SpCas9 gene editing in human cells. It enables the precise assessment of cleavage efficiency and specificity by providing benchmark positive and negative gRNAs targeting a known locus. These controls are essential for optimizing transfection or electroporation protocols, validating sgRNA delivery, and quantifying on-target indel formation for reliable data normalization.
- Validate SpCas9 editing activity with positive and negative controls for human gene targets.
- Establish a benchmark for quantifying on-target cleavage efficiency and indel formation.
- Normalize experimental data to distinguish delivery failure from ineffective gRNA design.
eSpOT-ON Recombinant Protein
eSpOT-ON nuclease is an engineered high-fidelity Cas9 protein designed for therapeutic applications. It offers high on-target editing efficiency while minimizing off-target activity, making it a safer choice for precise cell and gene therapy development. This Cas9 protein is optimized for both accuracy and safety, providing a reliable solution for your gene editing needs.
- Engineered for high on-target efficiency and reduced off-target effects.
- Minimizes off-target edits, enhancing safety in therapeutic applications.
- Produces staggered DNA cuts, which can improve DNA integration.
- Validated for safety and specificity in cell and gene therapies
eSpOT-ON is an engineered high-fidelity Cas9 variant, designed for therapeutic gene editing. Delivered in mRNA format, eSpOT-ON provides superior on-target activity with low off-target effects. This nuclease has been validated in preclinical studies and is ready to support your next breakthrough in cell and gene therapy development.
- Engineered for precise and safe genome editing.
- Significantly reduces off-target editing.
- Lowers the risk of chromosomal translocations.
- Validated in a wide range of human cell lines, including iPSCs.